Uger Robert

CIK 00018380471 companyMISSISSAUGA, A6

SEC Profile

Transactions

Companies

Filings

CIK

0001838047

Recent Transactions

44 trades

Disposition to Issuer
Trillium Therapeutics Inc.
Stock Option (Right to Buy)
2021-11-17−5,260→ 0 total
Disposition to Issuer
Trillium Therapeutics Inc.
Stock Option (Right to Buy)
2021-11-17−250,000→ 0 total
Disposition to Issuer
Trillium Therapeutics Inc.
Stock Option (Right to Buy)
2021-11-17−23,473→ 0 total
Disposition to Issuer
Trillium Therapeutics Inc.
Stock Option (Right to Buy)
2021-11-17−29,073→ 0 total
Disposition to Issuer
Trillium Therapeutics Inc.
Stock Option (Right to Buy)
2021-11-17−102,083→ 0 total
Disposition to Issuer
Trillium Therapeutics Inc.
Stock Option (Right to Buy)
2021-11-17−58,333→ 0 total
Exercise/Conversion
Trillium Therapeutics Inc.
Common Shares
2021-07-07$0.30/sh+3,646→ 3,646 total
Exercise/Conversion
Trillium Therapeutics Inc.
Stock Option (Right to Buy)
2021-07-07−3,646→ 102,083 total
Sale
Trillium Therapeutics Inc.
Common Shares
2021-07-07$9.00/sh−3,646→ 0 total
Sale
Trillium Therapeutics Inc.
Common Shares
2021-06-07$8.27/sh−3,646→ 0 total
Exercise/Conversion
Trillium Therapeutics Inc.
Common Shares
2021-06-07$0.32/sh+3,646→ 3,646 total
Exercise/Conversion
Trillium Therapeutics Inc.
Stock Option (Right to Buy)
2021-06-07−3,646→ 105,729 total
Exercise/Conversion
Trillium Therapeutics Inc.
Common Shares
2021-05-07$0.31/sh+3,646→ 3,646 total
Exercise/Conversion
Trillium Therapeutics Inc.
Stock Option (Right to Buy)
2021-05-07−3,646→ 109,375 total
Sale
Trillium Therapeutics Inc.
Common Shares
2021-05-07$9.30/sh−3,646→ 0 total
Exercise/Conversion
Trillium Therapeutics Inc.
Common Shares
2021-04-07$0.30/sh+3,646→ 3,646 total
Sale
Trillium Therapeutics Inc.
Common Shares
2021-04-07$10.82/sh−3,646→ 0 total
Exercise/Conversion
Trillium Therapeutics Inc.
Stock Option (Right to Buy)
2021-04-07−3,646→ 113,021 total
Exercise/Conversion
Trillium Therapeutics Inc.
Stock Option (Right to Buy)
2021-03-12−2,917→ 58,333 total
Sale
Trillium Therapeutics Inc.
Common Shares
2021-03-12$11.97/sh−2,917→ 0 total
Exercise/Conversion
Trillium Therapeutics Inc.
Common Shares
2021-03-12$3.39/sh+2,917→ 2,917 total
Sale
Trillium Therapeutics Inc.
Common Shares
2021-03-08$10.11/sh−3,646→ 0 total
Exercise/Conversion
Trillium Therapeutics Inc.
Common Shares
2021-03-08$0.30/sh+3,646→ 3,646 total
Exercise/Conversion
Trillium Therapeutics Inc.
Stock Option (Right to Buy)
2021-03-08−3,646→ 116,667 total
Exercise/Conversion
Trillium Therapeutics Inc.
Common Shares
2021-02-09$9.62/sh+584→ 584 total
Sale
Trillium Therapeutics Inc.
Common Shares
2021-02-09$14.12/sh−584→ 0 total
Exercise/Conversion
Trillium Therapeutics Inc.
Stock Option (Right to Buy)
2021-02-09−584→ 5,260 total
Exercise/Conversion
Trillium Therapeutics Inc.
Stock Option (Right to Buy)
2021-02-08−2,917→ 61,250 total
Exercise/Conversion
Trillium Therapeutics Inc.
Common Shares
2021-02-08$3.31/sh+2,917→ 6,563 total
Exercise/Conversion
Trillium Therapeutics Inc.
Stock Option (Right to Buy)
2021-02-08−3,646→ 120,313 total
Sale
Trillium Therapeutics Inc.
Common Shares
2021-02-08$12.65/sh−6,563→ 0 total
Exercise/Conversion
Trillium Therapeutics Inc.
Common Shares
2021-02-08$0.30/sh+3,646→ 3,646 total
Exercise/Conversion
Trillium Therapeutics Inc.
Common Shares
2021-01-11$9.57/sh+584→ 584 total
Sale
Trillium Therapeutics Inc.
Common Shares
2021-01-11$15.20/sh−584→ 0 total
Exercise/Conversion
Trillium Therapeutics Inc.
Stock Option (Right to Buy)
2021-01-11−584→ 5,844 total
Exercise/Conversion
Trillium Therapeutics Inc.
Common Shares
2021-01-08$11.01/sh+5,600→ 5,600 total
Sale
Trillium Therapeutics Inc.
Common Shares
2021-01-08$15.51/sh−2,917→ 0 total
Exercise/Conversion
Trillium Therapeutics Inc.
Stock Option (Right to Buy)
2021-01-08−2,917→ 64,167 total
Sale
Trillium Therapeutics Inc.
Common Shares
2021-01-08$15.82/sh−5,600→ 0 total
Exercise/Conversion
Trillium Therapeutics Inc.
Stock Option (Right to Buy)
2021-01-08−5,600→ 23,473 total
Exercise/Conversion
Trillium Therapeutics Inc.
Common Shares
2021-01-08$3.33/sh+2,917→ 2,917 total
Exercise/Conversion
Trillium Therapeutics Inc.
Stock Option (Right to Buy)
2021-01-07−3,646→ 123,959 total
Exercise/Conversion
Trillium Therapeutics Inc.
Common Shares
2021-01-07$0.30/sh+3,646→ 3,646 total
Sale
Trillium Therapeutics Inc.
Common Shares
2021-01-07$14.75/sh−3,646→ 0 total

Companies

Trillium Therapeutics Inc.
Chief Scientific Officer

Recent Filings

Address

C/O TRILLIUM THERAPEUTICS INC. 2488 DUNWIN DRIVE

MISSISSAUGA, A6, L5L 1J9

View on SEC.gov